• Home
  • Latest
  • Fortune 500
  • Finance
  • Tech
  • Leadership
  • Lifestyle
  • Rankings
  • Multimedia
Right Arrow Button IconLeft Arrow Button IconHome
Right Arrow Button IconPharmaceutical Industry

Pharmaceutical Industry

Page 58 of 100
White tablets
CommentaryHow Expanding Generic Drugs Can Add to America’s Health Care Woes
By Tim Calkins and Bethany CiancioloJuly 6, 2017
Former Turing Pharmaceuticals CEO Martin Shkreli On Trial For Securities Fraud
FinanceInvestor In Martin Shkreli’s Fund Says He Made Millions Despite Being Lied To
By ReutersJuly 6, 2017
Two Stories That Help Explain Runaway Drug Prices
HealthTwo Stories That Help Explain Runaway Drug Prices
By Clifton LeafJune 30, 2017
Stefano Pessina, Executive Deputy Chairm
RetailWalgreens Scraps Rite Aid Deal and Will Instead Buy 2,200 Stores for $5 Billion
By Phil WahbaJune 29, 2017
House Oversight Hearing On Prescription Drug Price Increases
Finance‘Pharma Bro’ Martin Shkreli Begins His Fraud Trial Monday
By ReutersJune 26, 2017
Mylan NV EpiPen 2-Pak medication sits on a table inside a pharmacy in Provo, Utah, U.S., on Wednesday, Aug. 31, 2016.
HealthWill the Newest EpiPen Competitor Steal Even More Market Share from Mylan?
By Sy MukherjeeJune 19, 2017
Pharmaceutical Drug Roundup Inside A Pharmacy
HealthMylan Shareholders Are Being Advised to Vote Against Board Members and Executive Pay Packages
By ReutersJune 12, 2017
Johns Hopkins Hospital Continues Cancer Research And Treatment
Health3 Key Takeaways from the World’s Biggest Cancer Conference
By Sy MukherjeeJune 6, 2017
Johnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
HealthJohnson & Johnson Drug Slashes Prostate Cancer Death Risk By Nearly 40%
By Sy MukherjeeJune 5, 2017
Herceptin Approved For Treatment Of Scottish Breast Cancer Patients
HealthRoche Loses Billions in Value After Pricey Breast Cancer Drug Combo Disappoints
By Sy MukherjeeJune 5, 2017
Robert J. Coury, vice chairman and chief executive officer o
HealthMylan’s Shareholders Fight to Dump Its Board After the Epipen Scandal
By ReutersMay 31, 2017
The Next Market Amazon Could Take Over
CommentaryThe Next Market Amazon Could Take Over
By Harry KraemerMay 18, 2017
Johnson & Johnson Products Ahead Of Earnings
HealthJohnson & Johnson Unveils Ambitious Multi-Billion Dollar Plan
By Sy MukherjeeMay 17, 2017
Prescription Botttle
HealthNew York County Sues Purdue Pharma and Johnson & Johnson Over Opioid Marketing
By ReutersMay 15, 2017
483106863
HealthWhy the Companies That Actually Make Your Drugs Are in a Merger Frenzy
By Sy MukherjeeMay 15, 2017
1...
  • 56
  • 57
  • 58
  • 59
  • 60
...100
Most Popular
Politics
'This is the last warning.' Iran threatens U.S. warships after they throw down the gauntlet for winner-take-all Strait of Hormuzplaceholder alt text
By Fortune EditorsApril 11, 2026
Real Estate
A 93-year-old refused to sell her home to the Masters golf course that’s spent $280 million on expansion: ‘Money ain’t everything’placeholder alt text
By Fortune EditorsApril 12, 2026
Economy
'People are trying to be creative': Tariff-battered American companies are so cash-starved they are using refund claims as collateral for loansplaceholder alt text
By Fortune EditorsApril 12, 2026
Fortune Secondary Logo
Rankings
  • 100 Best Companies
  • Fortune 500
  • Global 500
  • Fortune 500 Europe
  • Most Powerful Women
  • Future 50
  • World’s Most Admired Companies
  • See All Rankings
Sections
  • Finance
  • Fortune Crypto
  • Features
  • Leadership
  • Health
  • Commentary
  • Success
  • Retail
  • Mpw
  • Tech
  • Lifestyle
  • CEO Initiative
  • Asia
  • Politics
  • Conferences
  • Europe
  • Newsletters
  • Personal Finance
  • Environment
  • Magazine
  • Education
Customer Support
  • Frequently Asked Questions
  • Customer Service Portal
  • Privacy Policy
  • Terms Of Use
  • Single Issues For Purchase
  • International Print
Commercial Services
  • Advertising
  • Fortune Brand Studio
  • Fortune Analytics
  • Fortune Conferences
  • Business Development
  • Group Subscriptions
About Us
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • About Us
  • Editorial Calendar
  • Press Center
  • Work At Fortune
  • Diversity And Inclusion
  • Terms And Conditions
  • Site Map
  • Facebook icon
  • Twitter icon
  • LinkedIn icon
  • Instagram icon
  • Pinterest icon

© 2026 Fortune Media IP Limited. All Rights Reserved. Use of this site constitutes acceptance of our Terms of Use and Privacy Policy | CA Notice at Collection and Privacy Notice | Do Not Sell/Share My Personal Information
FORTUNE is a trademark of Fortune Media IP Limited, registered in the U.S. and other countries. FORTUNE may receive compensation for some links to products and services on this website. Offers may be subject to change without notice.